Candida biofilm formation and recurrent vulvovaginal candidiasis

被引：0
|
作者：
Sun, Yao [1 ,2 ]
Kostoulias, Xenia [1 ,3 ,4 ]
Qu, Yue [1 ,3 ,4 ]
机构：
[1] Monash Univ, Biomed Discovery Inst, Fac Med Nursing & Hlth Sci, Dept Microbiol, Clayton, Vic 3800, Australia
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Wenzhou 325000, Zhejiang, Peoples R China
[3] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic 3004, Australia
[4] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia
来源：
MICROBIOLOGY AUSTRALIA | 2023年
关键词：
antifungal resistance; biofilm formation; Candida species; pathogenesis; persistence; recurrence; vulvovaginal candidiasis; GENE-EXPRESSION; ALBICANS; EPIDEMIOLOGY; RESISTANCE; VIRULENCE; VAGINITIS; DEVICES; FAMILY;
D O I：
10.1071/MA23026
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Recurrent vulvovaginal candidiasis (RVVC), a recalcitrant Candida infection of the lower female reproductive tract, is a difficult-to-treat medical condition affecting the morbidity of many otherwise healthy women. Cumulative experimental evidence supports the involvement of biofilm formation of Candida in the pathogenesis of RVVC and its treatment failure. In this review, we will discuss important insights into the roles of Candida biofilms in RVVC.
引用
收藏
页码：92 / 95
页数：4
相关论文
共 50 条
  • [41] Risk factors for recurrent vulvovaginal candidiasis
    Farage, MA
    Stadler, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (03) : 981 - 982
  • [42] Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
    Grant, Leah M.
    Orenstein, Robert
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2022, 10
  • [43] A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis
    Casadevall, Arturo
    Pirofski, Liise-Anne
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (12) : 1937 - 1939
  • [44] Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
    Rosati, Diletta
    Bruno, Mariolina
    Jaeger, Martin
    ten Oever, Jaap
    Netea, Mihai G.
    MICROORGANISMS, 2020, 8 (02)
  • [45] Comment on treatment for recurrent vulvovaginal candidiasis
    Grinceviciene, Svitrigaile
    Donders, Gilbert G. G.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (04) : 426 - 427
  • [46] Risk factors for recurrent vulvovaginal candidiasis
    Jankovic, Slobodan
    Bojovic, Dragica
    Vukadinovic, Dubravka
    Daglar, Elmedina
    Jankovic, Marija
    Laudanovic, Dragomir
    Lukic, Vladan
    Miskovic, Vesna
    Potpara, Zorica
    Projovic, Ivana
    Cokanovic, Vesna
    Petrovic, Nadezda
    Folic, Marko
    Savic, Viktorija
    VOJNOSANITETSKI PREGLED, 2010, 67 (10) : 819 - 824
  • [47] Cellular immunity in recurrent vulvovaginal candidiasis
    Corrigan, EM
    Clancy, RL
    Dunkley, ML
    Eyers, FM
    Beagley, KW
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (03): : 574 - 578
  • [48] Insights and advances in recurrent vulvovaginal candidiasis
    Galan, Javier San Juan
    Poliquin, Vanessa
    Gerstein, Aleeza Cara
    PLOS PATHOGENS, 2023, 19 (11)
  • [49] In vitro antifungal susceptibility testing of Candida isolates from women with recurrent vulvovaginal candidiasis
    Antonopoulou, Stavroula
    Karageorgopoulos, Drosos
    Meletiadis, Joseph
    De Bernardis, Flavia
    MEDICAL MYCOLOGY, 2018, 56 : S36 - S36
  • [50] Recurrent vulvovaginal candidiasis Current management
    Watson, Cathy
    Pirotta, Marie
    AUSTRALIAN FAMILY PHYSICIAN, 2011, 40 (03) : 149 - 151
12345